StockNews.com started coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. A number of other research analysts also recently issued reports on ONCS. BTIG Research cut their price objective on OncoSec Medical from $10.00 to […]
Related Keywords
,Oncosec Medical Incorporated ,Long Focus Capital Management ,Goldman Sachs Group Inc ,Hightower Advisors ,Zacks Investment Research ,Susquehanna International Group ,Oncosec Medical ,Get Rating ,Investment Research ,Sec Medical ,International Group ,Tower Advisors ,Sachs Group ,Focus Capital Management ,Sec Medical Incorporated ,Nasdaq Oncs ,Concs ,Medical ,Initiated Coverage ,Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.